All In Biotech

Drug Trial Radar · NCT07049575

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

A Maximal Use Trial of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

Last checked: Nov 20, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Nov 3, 2025

Primary completion

Dec 9, 2026

Study completion Dec 9, 2026

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Jul 3, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the maximal use of ruxolitinib cream in adult and adolescent participants with hidradenitis suppurativa.

Conditions

  • Hidradenitis Suppurativa

Interventions

  • Ruxolitinib CreamDrug

    Ruxolitinib cream applied topically to the affected area as a thin film twice daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with Treatment-emergent Adverse Events (TEAEs)Time frame: Up to 24 weeks
  2. Number of participants with TEAEs leading to treatment interruption, discontinuationTime frame: Up to 24 weeks

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • Saguaro Dermatology

    Phoenix, Arizona · Recruiting

  • First Oc Dermatology

    Fountain Valley, California · Completed

  • Amicis Research Center Valencia

    Northridge, California · Recruiting

  • Children'S Hospital of Orange County

    Orange, California · Recruiting

  • Clinical Trials Research Institute

    Thousand Oaks, California · Recruiting

  • Clarity Dermatology

    Castle Rock, Colorado · Completed

  • International Clinical Research Tennessee Llc

    Sanford, Florida · Recruiting

  • Lenus Research Medical Group, Llc

    Sweetwater, Florida · Recruiting

  • Trueblue Clinical Research

    Tampa, Florida · Recruiting

  • Lane Dermatology and Dermatologic Surgery

    Columbus, Georgia · Recruiting

  • Options Research Group, Llc

    West Lafayette, Indiana · Recruiting

  • Equity Medical, Llc

    Bowling Green, Kentucky · Recruiting

  • Delricht Research

    Baton Rouge, Louisiana · Recruiting

  • Revival Research Institute, Llc Troy

    Troy, Michigan · Completed

  • Red River Research Partners

    Bolivar, Missouri · Recruiting

  • Dr Bobby Buka, Md Greenwich Village

    New York, New York · Recruiting

  • Equity Medical, Llc

    New York, New York · Recruiting

  • Red River Research Partners

    Fargo, North Dakota · Recruiting

  • Centricity Research Columbus

    Columbus, Ohio · Completed

  • Unity Clinical Research

    Oklahoma City, Oklahoma · Recruiting

  • Paddington Testing Co Inc

    Philadelphia, Pennsylvania · Completed

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.